Martin joined MVM in 2002. He was previously a member of the healthcare investment team at 3i. Prior to that, he was an Engagement Manager with McKinsey & Company based in London and Mumbai. Martin has a degree in Biochemistry from Oxford University and completed a Ph.D. in Molecular Biology at Cambridge before going on to postdoctoral work in Paris.
Martin is a member of the boards of Healthcare Brands International Ltd., Heptares Therapeutics Ltd., PregLem SA, Pulmagen Therapeutics Ltd., and Vantia Therapeutics Ltd.
